Nomura Research Institute (NRILY)
(Delayed Data from OTC)
$25.28 USD
-0.92 (-3.51%)
Updated Apr 26, 2024 03:59 PM ET
4-Sell of 5 4
C Value A Growth C Momentum B VGM
Income Statements
Fiscal Year end for Nomura Research Institute falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | NA | 5,122 | 5,444 | 4,971 | 4,861 |
Cost Of Goods | NA | 3,347 | 3,521 | 3,293 | 3,198 |
Gross Profit | NA | 1,775 | 1,923 | 1,678 | 1,662 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 974 | 1,010 | 889 | 898 |
Income After Depreciation & Amortization | 0 | 801 | 913 | 790 | 764 |
Non-Operating Income | NA | 43 | 50 | -44 | 181 |
Interest Expense | NA | 41 | 31 | 104 | 4 |
Pretax Income | NA | 803 | 932 | 642 | 942 |
Income Taxes | NA | 237 | 293 | 167 | 297 |
Minority Interest | NA | 1 | 3 | -3 | 9 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | 566 | 639 | 475 | 645 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | 565 | 636 | 478 | 637 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 1,135 | 1,286 | 1,159 | 1,044 |
Depreciation & Amortization (Cash Flow) | NA | 334 | 373 | 370 | 280 |
Income After Depreciation & Amortization | 0 | 801 | 913 | 790 | 764 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | NA | 591.89 | 593.69 | 598.44 | 635.15 |
Diluted EPS Before Non-Recurring Items | NA | 0.95 | 1.07 | 1.07 | 1.00 |
Diluted Net EPS (GAAP) | NA | 0.95 | 1.07 | 0.80 | 4.11 |
Fiscal Year end for Nomura Research Institute falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 1,272.82 | 1,282.85 | 1,289.98 | 1,331.71 |
Cost Of Goods | NA | NA | NA | 828.83 | NA |
Gross Profit | NA | NA | NA | 461.15 | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 258.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 203.15 | 0.00 |
Non-Operating Income | NA | NA | NA | 1.68 | NA |
Interest Expense | NA | NA | NA | 10.80 | NA |
Pretax Income | NA | NA | NA | 194.03 | NA |
Income Taxes | NA | NA | NA | 67.79 | NA |
Minority Interest | NA | NA | NA | 0.61 | NA |
Investment Gains/Losses | NA | NA | NA | 0.00 | NA |
Other Income/Charges | NA | NA | NA | 0.00 | NA |
Income From Cont. Operations | NA | 158.68 | 141.55 | 126.25 | 160.87 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 158.68 | 141.55 | 125.64 | 160.87 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 578.12 | 584.68 | 590.40 | 593.75 |
Diluted EPS Before Non-Recurring Items | NA | 0.27 | 0.24 | 0.21 | 0.27 |
Diluted Net EPS (GAAP) | NA | 0.27 | 0.24 | 0.21 | 0.27 |